Stephen Basil Thomas, Director at Climb Bio, Inc. (CLYM), sold 100,000 shares at $13.67 ($1.4M) on 2026-09-15, disclosed to the SEC on 2026-09-17.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |